Top 15 Diabetes Drugs in 2023 by 2022 Sales Statistics
XTalks
FEBRUARY 8, 2024
In 2022, Januvia was flagged for nitrosamine contamination , a potential carcinogen commonly produced as a byproduct during drug manufacturing. According to AstraZeneca, the drug had strong demand across all of its approved indications and was further supported by recent guideline updates from cardiology societies. from $289.36.
52 
Let's personalize your content